Schedule 13D ownership disclosure
ABRDN LIFE SCIENCES INVESTOR
Common Shares, $0.01 par value · CUSIP: 87911K100
Event date: 2026-01-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Saba Capital Management, L.P.Reported CIK 0001510281
Shares: 2,002,516 · Class: 6.77%
- Boaz R. WeinsteinReported CIK 0001608233
Shares: 2,002,516 · Class: 6.77%
- Saba Capital Management GP, LLC
Shares: 2,002,516 · Class: 6.77%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-26-000129
- Form type
- SCHEDULE 13D/A
- Filer
- Saba Capital Management, L.P.
- CIK
- CIK 1510281
- Filed
- Jan 08, 2026
- Reporting period
- Jan 07, 2026
- Description
- Schedule 13D beneficial ownership